The Global Artemisinin API Market was valued at US$ 1.8 Billion in 2023 and is projected to reach US$ 2.6 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2024–2030). This sustained growth is fueled by the persistent global fight against malaria, the rising adoption of Artemisinin-based Combination Therapies (ACTs), and increasing government and WHO-led initiatives for malaria eradication programs, particularly across the Asia-Pacific and African regions.

As the pharmaceutical industry intensifies its focus on combating infectious diseases, the Artemisinin API sector is experiencing significant innovation in production technologies and supply chain optimization. In this blog, we profile the Top 10 Companies in the Artemisinin API Industry—a strategic mix of global pharmaceutical giants and specialized botanical extract manufacturers who are ensuring a stable and high-quality supply of this life-saving active pharmaceutical ingredient.

Download FREE Sample Report:
Artemisinin API Market – View in Detailed Research Report

---

🔟 1. Sanofi

Headquarters: Paris, France
Key Offering: High-Purity Artemisinin API, Semisynthetic Artemisinin

Sanofi stands as a global leader in the pharmaceutical sector and is a major supplier of Artemisinin API. Through strategic partnerships and its own production facilities, Sanofi plays a critical role in the global ACT supply chain, ensuring consistent quality and volume for drug manufacturers worldwide.

Key Initiatives & Strengths:

• Large-scale production capabilities for semisynthetic artemisinin

• Long-term supply agreements with global health organizations

• Significant investment in R&D for optimizing artemisinin yields and synthesis processes

---

9️⃣ 2. KPC Pharmaceuticals, Inc.

Headquarters: Kunming, Yunnan, China
Key Offering: Artemisinin API Extracted from Artemisia annua

KPC Pharmaceuticals is one of the largest manufacturers of Artemisinin in China, leveraging its proximity to major cultivation areas of Artemisia annua. The company has vertically integrated operations, from plant cultivation to the extraction and purification of the API.

Key Initiatives & Strengths:

• Vertically integrated supply chain ensuring traceability and cost control

• Extensive experience in traditional Chinese medicine and botanical extraction

• Strong domestic and international client base

---

8️⃣ 3. Guilin Pharmaceutical Co., Ltd.

Headquarters: Guilin, Guangxi, China
Key Offering: Artemisinin, Dihydroartemisinin, Artemisinin-based Formulations

A subsidiary of the Shanghai Fosun Pharmaceutical Group, Guilin Pharmaceutical is a cornerstone of the global artemisinin supply. The company is renowned for its high-quality APIs and finished dosage forms, contributing significantly to the WHO’s malaria treatment programs.

Key Initiatives & Strengths:

• WHO prequalification for its artemisinin-based products

• Advanced manufacturing facilities compliant with international GMP standards

• Pioneering role in the development and commercialization of ACTs

Download FREE Sample Report:
Artemisinin API Market – View in Detailed Research Report

---

7️⃣ 4. Natural Bio-engineering Co., Ltd.

Headquarters: Bengbu, Anhui, China
Key Offering: Botanical Extracts including Artemisinin API

Natural Bio-engineering specializes in the extraction and purification of natural plant-based compounds. The company is a key supplier of Artemisinin API, focusing on efficient extraction technologies to maximize yield and purity from cultivated Artemisia annua.

Key Initiatives & Strengths:

• Focus on green extraction technologies

• Diversified portfolio of botanical extracts mitigating market risks

• Strong R&D capabilities in natural product chemistry

---

6️⃣ 5. BIONEXX

Headquarters: Cape Town, South Africa
Key Offering: African-grown Artemisinin API

BIONEXX is a leading African-based producer of Artemisinin, championing local cultivation and processing of Artemisia annua. This initiative not only creates a sustainable local supply chain but also promotes economic development in malaria-endemic regions.

Key Initiatives & Strengths:

• Localized production in Africa, reducing supply chain dependencies

• Commitment to ethical sourcing and fair trade practices with local farmers

• Strategic focus on improving healthcare access within Africa

---

5️⃣ 6. Novanat Bioresource

Headquarters: Changsha, Hunan, China
Key Offering: High-Purity Artemisinin and Derivatives

Novanat Bioresource is a specialized manufacturer dedicated to the research, development, and production of Artemisinin and its key derivatives. The company is known for its technical expertise and consistent product quality, serving both domestic and international markets.

Key Initiatives & Strengths:

• Strong focus on R&D for derivative synthesis (e.g., Dihydroartemisinin, Artesunate)

• Agile manufacturing operations capable of meeting custom purity specifications

• Established reputation for reliability among global pharmaceutical clients

---

4️⃣ 7. CAT KHANH

Headquarters: Vietnam
Key Offering: Artemisinin Extract from Vietnamese Artemisia annua

CAT KHANH is a prominent player in Southeast Asia, contributing to the regional Artemisinin supply. The company leverages favorable climatic conditions in Vietnam for cultivating Artemisia annua and has developed efficient processing capabilities.

Key Initiatives & Strengths:

• Development of a regional supply chain for Southeast Asian markets

• Cost-competitive production due to local cultivation advantages

• Growing export operations to international pharmaceutical companies

---

3️⃣ 8. BEEPZ

Headquarters: India
Key Offering: Artemisinin API for Antimalarial Formulations

BEEPZ is an emerging supplier in the global API market, with a growing focus on Artemisinin. The company benefits from India’s strong generic pharmaceutical manufacturing base and expertise in API production, aiming to become a significant alternative source.

Key Initiatives & Strengths:

• Strategic positioning within India’s robust pharmaceutical industry

• Investment in scaling up Artemisinin extraction and purification capabilities

• Focus on achieving regulatory approvals for international markets

---

2️⃣ 9. Kerui nanhai

Headquarters: China
Key Offering: Artemisinin and other Fine Chemical Intermediates

Kerui nanhai operates as a reliable manufacturer of fine chemicals, including Artemisinin API. The company supplies to various pharmaceutical intermediates distributors and formulation companies, emphasizing consistent quality and competitive pricing.

Key Initiatives & Strengths:

• Diversified product portfolio reduces vulnerability to market fluctuations

• Established distribution network for chemical intermediates

• Focus on process optimization to maintain cost efficiency

---

1️⃣ 10. Guangxi xiancaotang

Headquarters: Guangxi, China
Key Offering: Natural Artemisinin Extract

Guangxi xiancaotang specializes in the cultivation and extraction of medicinal plants, with Artemisinin being a key product. The company utilizes the rich botanical resources of the Guangxi region to produce natural Artemisinin API for the pharmaceutical industry.

Key Initiatives & Strengths:

• Expertise in sustainable agricultural practices for Artemisia annua cultivation

• Direct control over raw material quality from seed to extract

• Commitment to producing natural-origin APIs

Get Full Report Here:
Artemisinin API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Artemisinin API is Driven by Innovation and Accessibility

The Artemisinin API market is undergoing a significant transformation. While natural extraction remains dominant, the industry is increasingly embracing biotechnological advancements and supply chain diversification to meet the growing global demand for effective antimalarial treatments.

📈 Key Trends Shaping the Market:

• Accelerated R&D in semisynthetic and biosynthetic production methods to ensure supply stability

• Strategic shift towards localized API production in Africa to bolster regional health security

• Increasing stringency of international quality standards (e.g., WHO prequalification, GMP)

• Exploration of Artemisinin’s potential in new therapeutic areas beyond malaria

Get Full Report Here:
Artemisinin API Market – View in Detailed Research Report

The companies listed above are not only critical suppliers of a life-saving medicine—they are at the forefront of innovative production and sustainable sourcing that will define the future of global health security against malaria.